CJC-1295 (No DAC) + Ipamorelin

CJC-1295 (No DAC) + Ipamorelin is examined in research models to evaluate dual-receptor signaling pathways involving GHRH receptor activation and ghrelin receptor agonism.

Professional pricing

Sign in or create a research account to see prices and add this material to your order. Access unlocks as soon as you create your account.

In stock — ready to ship
Controlled handling

Shipment issuesWe do not accept returns on released material. Wrong item, damage, or a missing package is resolved directly.

Specifications

Product & molecular data

Lot & handling

SKU: SR-2182
Category: Endocrine Research
Storage: -20 °C, sealed, protected from light
Availability: In stock

Molecular

Sequence: Not available
Molecular formula: Not available
Molecular weight: Not available
CAS number: N/A
Storage conditions: −20 °C sealed and desiccated, protected from light
Format: Lyophilized Vial

Analytics

Testing & quality

When a lot certificate is on file we report identity, purity, and appearance. We publish analytical data only — never dosing information or outcome claims.

RP-HPLC

Chromatographic purity against a qualified reference standard.

LC-MS / ESI-MS

Identity by observed versus theoretical molecular mass.

Karl Fischer / Loss on Drying

Residual moisture in lyophilized material.

Endotoxin & Bioburden

Contaminant screening on raw material and finished lots.

Read the Quality Statement →

Research background

Published research context

Summary of the published literature this reference material is used in.

Telomere Biology

Investigated in cell-culture models of telomere maintenance and replicative ageing.

Gene Expression

Studied for reported effects on transcriptional regulation in experimental systems.

Senescence Models

Referenced in literature examining cellular senescence markers in vitro.

Dual Receptor Signaling Model

CJC-1295 (No DAC) is associated with GHRH receptor interaction, while Ipamorelin is a ghrelin receptor agonist studied for selective pathway engagement [1,2]. Researchers pair these peptides to evaluate pathway coordination, signaling timing, and response patterns in controlled experimental systems.

Selectivity and Pathway Isolation

Ipamorelin is often described in research literature as having notable receptor selectivity [2]. In combination models, this selectivity can support study designs that aim to isolate ghrelin-receptor-linked signaling while simultaneously tracking GHRH-related pathway markers.

Assay Timing and Comparative Studies

Combination studies often focus on signal timing, receptor sensitivity, and marker-based outcomes rather than isolated single-variable analysis. These approaches help researchers compare pathway dynamics across experimental conditions and peptide panels [1,2].

Key Specs